PATENT CLAIM ANALYSIS

Application Number: 15991333
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "04400R"]

Abstract:
Disclosed herein are Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated (Cas) 9-based system related compositions and methods of using said CRISPR/Cas9-based system related compositions for altering gene expression and genome engineering. Also disclosed herein are compositions and methods of using said compositions for altering gene expression and genome engineering in muscle, such as skeletal muscle and cardiac muscle.

Claim (Index 13):
An isolated polynucleotide encoding the DNA targeting system of  claim 1 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.65
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15127087', '14105017', '15746653', '15549842', '14775869']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8095639704911346
- 35 USC 102 Novelty (BERT): 0.5939176704332365
- Combined Prediction Score: 0.7879993404853448
- Mean Citation Score: 492.74871
- Max Citation Score: 566.38007
- Similarity Product: 425.15633269391657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test